Telemedicine is a growing resources for Houstonians, but here's what you need to know about tapping into digital health care. Ian Hooton/Getty Images

When health issues crop up, people often have to decide where best to seek medical attention, with urgent care and the emergency room being potential destinations. But for more and more Houston residents, their smartphone is now the preferred way to see and talk to a doctor.

Telemedicine visits, also known as virtual care, typically last less than 20 minutes, often cost less than $50 and enable people to connect 24/7 with a health care provider via a smartphone, tablet or personal computer to help diagnose and treat certain medical conditions. While nearly 40 percent of Americans said they are interested in using telemedicine in the future to access care a separate J.D. Power survey found nationwide telehealth adoption is currently as low as 10 percent.

Closing this gap by expanding the use of virtual care may prove beneficial, as this technology can provide consumers improved convenience and lower costs. In fact, 68 percent of patients rated their telemedicine visit a "nine" or "10" on a 10-point satisfaction scale; 74 percent had their care concern resolved during the first visit; and net savings per virtual visit exceeded $120.

To help people take advantage of this emerging technology, here are four tips to consider:

Identify Available Resources
Among people who had not used telemedicine, the J.D. Power survey found that 37 percent said they did not know if they had access to this technology. To find telemedicine resources that may be available to you, check with your hospital or care provider group, health insurance plan or employer. In fact, nearly nine out of 10 employers are offering telemedicine to their employees, while 76 percent of U.S. hospitals already connect patients and care providers using video or other technology. For Medicare beneficiaries, some Medicare Advantage plans are offering coverage for telemedicine and resources to access virtual care, in some cases at no out-of-pocket cost.

For Houston residents, most people enrolled in UnitedHealthcare employer-sponsored plans have coverage for virtual physician visits, giving plan participants secure, online access to a physician via mobile phone, tablet or computer 24 hours a day. Several Houston-area hospitals and provider groups have also introduced virtual care resources, and changes in state regulations in 2017 helped spur additional national telemedicine companies to start serving the market.

Understand Appropriate Uses
While telemedicine may have the potential to help treat other health issues, the technology is most widely used to address minor and nonemergency medical conditions, including allergies, flu, pinkeye, and rashes. Telemedicine is also emerging as a helpful resource for behavioral health services, making it more convenient for people to access this type of care. If needed, doctors can prescribe medications and send prescriptions to local pharmacies for pickup. While people who experience a significant or serious medical issue should go to the emergency room (ER), it is important to recognize that about 25 percent of ER visits typically involve conditions that could appropriately be addressed with a virtual visit.

Keep Your Primary Care Physician
Telemedicine may be ideal for treating minor and nonemergency medical issues, but it is important for people to maintain a relationship with a primary care physician for wellness checkups, diagnostics, management of long-term conditions and some urgent and non-urgent treatments. As telemedicine programs evolve, people may have the option to use virtual visits to access primary care and maintain an on-going relationship with their preferred doctor.

Other Connected Devices
Consumers can consider other connected devices to help access care and potentially improve their health, ranging from smartwatches and activity trackers to continuous blood glucose monitors and connected asthma inhalers. These connected devices – and others like them – may provide important real-time information and offer people actionable feedback about their behavior patterns, while helping make it possible for care providers to counsel patients to more effectively follow recommended treatments.

Making telemedicine more widely available – and used – may be especially important for people with chronic conditions and the 20 percent of the U.S. population that lives in rural areas where access to health care, particularly specialty care, is often lacking. By considering these tips, people may make the most of telemedicine resources as part of their journey toward managing their health.

------

Dave Milich is the CEO of UnitedHealthcare of Texas.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.